Corrigendum to "Randomized, blind, controlled phase III clinical trial: Assessing the immunogenicity and safety of freeze-dried human rabies vaccine (vero cell) with a 4-dose regimen (2-1-1) in a 10-60 year-old demographic" [Vaccine (2024) 26059]
Vaccine. 2024 Oct 3;42(23):126128.
doi: 10.1016/j.vaccine.2024.07.029.
Epub 2024 Jul 16.